The CD112-TIGIT/PVRIG Axis Mediates NK Cell Evasion in Decitabine-Treated Acute Myeloid Leukemia Cells
Findings identify CD112 upregulation, which is associated with enhancer demethylation, as a mechanism of drug-induced immune evasion in AML and provide a rationale for combining hypomethylating agents with blockade of the CD112-TIGIT/PVRIG axis to enhance NK cell-mediated antileukemic activity.